Tom Cole shares thoughts on Twitter

Tom Cole shares thoughts on Twitter
0Comments

Tom Cole tweeted the following:

“Earlier this morning, I joined @OKCFOX for a live interview to share my thoughts on @POTUS’ #SOTU last night.
Watch below!”
Read on Twitter

Here are other recent tweets from Tom Cole:

“ICYMI: Yesterday, I joined @JerryMoran & @RogerMarshallMD in sending a letter to @POTUS urging an immediate embargo on U.S. purchase of Russian energy exports, which are funding Putins war machine amid its unprovoked aggression against Ukraine.”
Read on Twitter
“While I was encouraged @POTUS used his #SOTU address to further condemn Putins unprovoked aggression against Ukraine, he also tried to use the speech before Congress to rewrite his first year & paint missteps & failures as successes.
My full statement
cole.house.gov/media-center/p
Read on Twitter
“While there are many things that could come up in tonight’s #SOTU, @POTUS will be remembered most for how he addresses Russia’s unprovoked invasion of Ukraine. Viewed by friends & adversaries around the globe, he has the opportunity to bring resolve to the table.” on March 1
Read on Twitter



Related

Caleb Michaud, Acting Associate Commissioner for External Affairs of FDA

FDA conducted inspections of 3 companies in cities located in Comanche County in 2025

There were three companies in a city associated with Comanche County that received three FDA inspections in 2025, according to the U.S. Food and Drug Administration.

Grace Graham, Deputy Commissioner for Policy, Legislation, and International Affairs of FDA

1 company in a city within Jackson County received one inspection in 2025

There was one company in a city associated with Jackson County that received an FDA inspection in 2025, according to the U.S. Food and Drug Administration.

Grace Graham, Deputy Commissioner for Policy, Legislation, and International Affairs of FDA

Washita County cities: 1 company received an FDA inspection in 2025

There was one company in a city associated with Washita County that received an FDA inspection in 2025, according to the U.S. Food and Drug Administration.